MetLife Investment Management, LLC - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 125 filers reported holding INOVIO PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.29 and the average weighting 0.0%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$103,784
-31.3%
126,566
+30.6%
0.00%0.0%
Q4 2022$151,137
-26.3%
96,883
-18.5%
0.00%
-50.0%
Q3 2022$205,161
+77.0%
118,934
+77.5%
0.00%
+100.0%
Q2 2022$115,894
-71.8%
66,991
-41.4%
0.00%
-66.7%
Q1 2022$410,545
+12.6%
114,358
+56.5%
0.00%0.0%
Q4 2021$364,634
-15.3%
73,073
+21.5%
0.00%
-25.0%
Q3 2021$430,631
-34.3%
60,144
-15.0%
0.00%
-33.3%
Q2 2021$655,760
-0.1%
70,7400.0%0.01%0.0%
Q1 2021$656,467
+11.8%
70,740
+6.7%
0.01%0.0%
Q4 2020$586,941
-23.7%
66,3210.0%0.01%
-25.0%
Q3 2020$769,324
-54.9%
66,321
+4.8%
0.01%
-57.9%
Q2 2020$1,705,719
+393.3%
63,292
+36.2%
0.02%
+280.0%
Q1 2020$345,767
+125.5%
46,4740.0%0.01%
+150.0%
Q4 2019$153,364
+43.7%
46,474
+28.0%
0.00%
+100.0%
Q2 2019$106,713
-21.2%
36,2970.0%0.00%
-50.0%
Q1 2019$135,388
-6.7%
36,2970.0%0.00%0.0%
Q4 2018$145,188
-28.1%
36,2970.0%0.00%0.0%
Q3 2018$201,811
+42.1%
36,2970.0%0.00%0.0%
Q2 2018$142,000
-17.0%
36,2970.0%0.00%0.0%
Q1 2018$171,000
+14.0%
36,2970.0%0.00%0.0%
Q4 2017$150,00036,2970.00%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Affinity Asset Advisors, LLC 200,000$998,0000.36%
Green Alpha Advisors, LLC 72,647$363,0000.24%
Skaana Management L.P. 227,851$1,137,0000.18%
SEVEN EIGHT CAPITAL, LP 196,351$980,0000.18%
Defender Capital, LLC. 103,038$514,0000.16%
Skaana Management L.P. 206,300$1,029,0000.16%
WASATCH ADVISORS LP 4,926,125$24,581,0000.10%
Parametrica Management Ltd 16,183$81,0000.08%
Cedar Brook Financial Partners, LLC 54,500$272,0000.07%
Hennion & Walsh Asset Management, Inc. 274,703$1,371,0000.07%
View complete list of INOVIO PHARMACEUTICALS INC shareholders